Crinetics Pharmaceuticals... (CRNX)
NASDAQ: CRNX
· Real-Time Price · USD
30.92
1.52 (5.17%)
At close: Aug 22, 2025, 3:59 PM
30.98
0.19%
After-hours: Aug 22, 2025, 07:57 PM EDT
Crinetics Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -369.83M | -328.25M | -298.41M | -277.91M | -258.54M | -235.46M | -214.53M | -199.42M | -183.89M | -175.29M | -163.92M | -149.72M | -135.65M | -119.37M | -107.64M | -98.49M | -88.96M | -79.35M |
Depreciation & Amortization | 3.44M | 3.24M | 2.79M | 2.26M | 1.76M | 1.29M | 1.1M | 1.12M | 1.09M | 1.03M | 983K | 938K | 923K | 938K | 922K | 912K | 923K | 937K |
Stock-Based Compensation | 83.59M | 76.41M | 69.39M | 62.16M | 55.06M | 46.3M | 40.94M | 37.27M | 33.65M | 30.61M | 28.27M | 25.48M | 22.6M | 19.7M | 17.35M | 15.16M | 13.39M | 11.69M |
Other Working Capital | -12.82M | -18.19M | -8.62M | 4.11M | 10.13M | -5.88M | -6.6M | -11.1M | -14.45M | -4.06M | 7.42M | 7.22M | 6.83M | 7.62M | -5.2M | -4.16M | -2.93M | -3.53M |
Other Non-Cash Items | -4.6M | -423K | 575K | 5.38M | 3.35M | 6.13M | 6.26M | 4.04M | -3.14M | -2.99M | 850K | 666K | 790K | 608K | -739K | 332K | 315K | 295K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -7.21M | -8.12M | -8.12M | -8.12M | -905K | n/a | n/a | 186K | 252K | 339K | 422K | 302K | 236K | 36K |
Change in Working Capital | -14.4M | -12.54M | -308K | 8.3M | 27.25M | 11.42M | 8.04M | 2.11M | -6.95M | 4.26M | 18.61M | 19.56M | 20.99M | 15.72M | 1.1M | 150K | 134K | -3.46M |
Operating Cash Flow | -301.8M | -261.57M | -225.97M | -199.81M | -178.33M | -178.44M | -166.31M | -163M | -160.14M | -142.38M | -115.2M | -102.9M | -90.09M | -82.06M | -88.59M | -81.63M | -73.96M | -69.86M |
Capital Expenditures | -6M | -3.75M | -3.84M | -3.75M | -6.72M | -6M | -4.69M | -4.03M | -1.21M | -1.58M | -1.66M | -1.4M | -858K | -407K | -436K | -435K | -392K | -242K |
Cash Acquisitions | n/a | n/a | n/a | n/a | 189.8M | 158.12M | 157.59M | 157.63M | -39.67M | 165.66M | 166.51M | 268.27M | 275.78M | 102.12M | 101.88M | -547K | -547K | -547K |
Purchase of Investments | -1.45B | -1.45B | -1.16B | -605.56M | -742.42M | -609.93M | -532.86M | -393.37M | -164.41M | -297.47M | -329.82M | -398.28M | -370.44M | -177.89M | -125.4M | -45.21M | -68.03M | -115.24M |
Sales Maturities Of Investments | 865.63M | 780.9M | 575.8M | 478.51M | 415.21M | 367.07M | 337.13M | 321.14M | 289.49M | 217.22M | 157.49M | 87.05M | 44.82M | 45.92M | 69.36M | 82.07M | 87.03M | 131.86M |
Other Investing Acitivies | 19.86M | 10.77M | 10.77M | 10.77M | -189.8M | -158.12M | -157.59M | -157.63M | 39.67M | -165.66M | -166.51M | -268.27M | -282.66M | -89M | -88.77M | 13.66M | -4.19M | -6.57M |
Investing Cash Flow | -569.49M | -661.09M | -574.82M | -120.04M | -333.94M | -248.86M | -200.41M | -76.25M | 123.87M | -81.84M | -173.98M | -312.63M | -326.48M | -132.37M | -56.48M | 36.42M | 18.62M | 16.38M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 10.68M | 10.68M | 21.04M | 30.21M | 28.45M | 29.8M | 19.93M | 10.87M | 3.02M | 120.67M | 121.96M | 123.7M | 123.11M | 4.86M | 3.14M | 1.39M | 963K | 290K |
Financial Cash Flow | 622.86M | 621.3M | 1.01B | 494.32M | 774.87M | 782.03M | 388.94M | 351.13M | 14.33M | 120.67M | 121.96M | 285.7M | 300.09M | 254.4M | 252.68M | 88.92M | 73.3M | 108.15M |
Net Cash Flow | -248.44M | -301.36M | 209.65M | 174.47M | 262.61M | 354.73M | 22.22M | 111.88M | -21.94M | -103.55M | -167.22M | -129.82M | -116.48M | 39.97M | 107.61M | 43.72M | 17.96M | 54.66M |
Free Cash Flow | -307.8M | -265.32M | -229.81M | -203.56M | -185.05M | -184.45M | -171M | -167.03M | -161.35M | -143.97M | -116.86M | -104.3M | -90.95M | -82.47M | -89.02M | -82.06M | -74.35M | -70.11M |